| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ArrhythmiaAdenosineHeart (Inherited and congenital diseases)Electrophysiological examination of the heartHeart failure (chronical)Coronary heart disease (BASKET)Heart (Anatomy)VerapamilElectrocardiographyOmega3 fatty acidsHeart (Atrial fibrillation)Antiarrhythmic agentsBrugada syndromeReceptor (Ryanodine)Gap junctionIschemia reperfusionHeart (Ventricular fibrillation)StatinMitochondrium (BASKET)Heart (Inherited and congenital diseases in grown up patients)Cardiomyopathy (BASKET)| 1 | 2006 | Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis. | 
| + | - | nl | Clin Med Res 4(1):42-52 (2006) Li J |
| 2 | 2008 | Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system. | 
| + | - | nl | Cleve Clin J Med 75 Suppl 2():S94-6 (2008) Zipes DP |
| 3 | 2008 | Initial management of cardiac arrhythmias. | 
| + | - | nl | Aust Fam Physician 37(7):516-20 (2008) Cruickshank J |
| 4 | 2007 | Emergency management of acute cardiac arrhythmias. | 
| + | - | nl | Aust Fam Physician 36(7):492-7 (2007) Grantham HJ |
| 5 | 1997 | Perioperative cardiac dysrhythmias: diagnosis and management. | 
| + | - | nl | Anesthesiology 86(6):1397-424 (1997) |
| 6 | 1990 | Mechanisms for cardiac dysrhythmias during anesthesia. | 
| + | - | nl | Anesthesiology 72(2):347-74 (1990) |
| 7 | 2005 | Genetics of cardiac arrhythmias. | 
| + | - | nl | Heart 91(10):1352-8 (2005) Wilde AA |
| 8 | 1990 | Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias. | 
| + | - | nl | Br Heart J 63(1):3-4 (1990) |
| 9 | 2010 | Sodium channel (dys)function and cardiac arrhythmias. | 
| + | - | nl | Cardiovasc Ther 28(5):287-94 (2010) Remme CA |
| 10 | 2008 | Role of potassium currents in cardiac arrhythmias. | 
| + | - | nl | Europace 10(10):1133-7 (2008) Ravens U |
| 11 | 2006 | ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | 
| + | - | nl | Europace 8(9):746-837 (2006) Zipes DP |
| 12 | 2005 | Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry. | 
| + | - | nl | Europace 7 Suppl 2():10-20 (2005) Comtois P |
| 13 | 2005 | Mechanisms of inherited cardiac conduction disease. | 
| + | - | nl | Europace 7(2):122-37 (2005) Smits JP |
| 14 | 2008 | Drug therapy considerations in arrhythmias in children. | 
| + | - | nl | Indian Pacing Electrophysiol J 8(3):202-10 (2008) Ramesh Iyer V |
| 15 | 2008 | Difficulties with ablation for arrhythmias in children. | 
| + | - | nl | Indian Pacing Electrophysiol J 8(Suppl. 1):S55-74 (2008) Asirvatham SJ |
| 16 | 2003 | Role of adenosine/ATP test in supraventricular tachycardia. | 
| + | - | nl | Indian Pacing Electrophysiol J 3(1):1-2 (2003) Francis J |
| 17 | 2005 | Animal models for arrhythmias. | 
| + | - | nl | Cardiovasc Res 67(3):426-37 (2005) Milan DJ |
| 18 | 2005 | The molecular genetics of arrhythmias. | 
| + | - | nl | Cardiovasc Res 67(3):343-6 (2005) Bezzina CR |
| 19 | 2005 | Susceptibility genes and modifiers for cardiac arrhythmias. | 
| + | - | nl | Cardiovasc Res 67(3):397-413 (2005) Kaab S |
| 20 | 2004 | Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. | 
| + | - | nl | Cardiovasc Res 61(2):208-17 (2004) Janse MJ |
| 21 | 2001 | New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1). | 
| + | - | nl | Cardiovasc Res 52(3):345-60 (2001) |
| 22 | 2001 | Pharmacogenetics and drug-induced arrhythmias. | 
| + | - | nl | Cardiovasc Res 50(2):224-31 (2001) |
| 23 | 2001 | Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? | 
| + | - | nl | Cardiovasc Res 50(2):218-23 (2001) |
| 24 | 1999 | Role of sympathoadrenergic mechanisms in arrhythmogenesis. | 
| + | - | nl | Cardiovasc Res 43(4):832-4 (1999) |
| 25 | 1999 | Are the arrhythmias due to myocardial ischaemia and infarction dependent upon the sympathetic system? | 
| + | - | nl | Cardiovasc Res 43(4):830-1 (1999) |
| 26 | 1999 | Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. | 
| + | - | nl | Cardiovasc Res 42(2):309-17 (1999) |
| 27 | 1998 | Damage-induced arrhythmias: reversal of excitation-contraction coupling. | 
| + | - | nl | Cardiovasc Res 40(3):444-55 (1998) |
| 28 | 1998 | Role of cardiac chloride currents in changes in action potential characteristics and arrhythmias. | 
| + | - | nl | Cardiovasc Res 40(1):23-33 (1998) |
| 29 | 1998 | Animal models of cardiac arrhythmias. | 
| + | - | nl | Cardiovasc Res 39(1):165-77 (1998) |
| 30 | 1998 | The membrane current (I(f)) in human atrial cells: implications for atrial arrhythmias. | 
| + | - | nl | Cardiovasc Res 38(3):537-40 (1998) |
| 31 | 1996 | Mahaim, Kent and abnormal atrioventricular conduction. | 
| + | - | nl | Cardiovasc Res 31(4):480-91 (1996) |
| 32 | 1986 | Verapamil in arrhythmia. | 
| + | - | nl | Br J Clin Pharmacol 21 Suppl 2(-):183S-189S (1986) |
| 33 | 1978 | The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias. | 
| + | - | nl | Br J Clin Pharmacol 6(6):473-85 (1978) |
| 34 | 2005 | Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias. | 
| + | - | nl | Acta Pharmacol Sin 26(8):918-25 (2005) Dai DZ |
| 35 | 2006 | Pathophysiological mechanism of cardiac arrhythmias as a key for optimal nonpharmacological treatment. | 
| + | - | nl | J Physiol Pharmacol 57 Suppl 11():69-77 (2006) Kozluk E |
| 36 | 1997 | Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. | 
| + | - | nl | J Nutr 127(3):383-93 (1997) |
| 37 | 2008 | Molecular mechanisms of inherited arrhythmias. | 
| + | - | nl | Curr Genomics 9(3):160-8 (2008) Wolf CM |
| 38 | 1989 | Results of direct surgical ablation of ventricular tachycardia not due to ischemic heart disease. | 
| + | - | nl | Ann Surg 209(6):716-27 (1989) |
| 39 | 2007 | Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 293(4):H2024-38 (2007) Antzelevitch C |
| 40 | 2006 | In vivo dispersion in repolarization and arrhythmias in the human heart. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 290(1):H77-8 (2006) Opthof T |
| 41 | 2004 | Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 286(3):H815-22 (2004) Gepstein L |
| 42 | 1994 | Radiofrequency catheter ablation for cardiac tachyarrhythmias. | 
| + | - | nl | Ann Intern Med 121(6):452-61 (1994) |
| 43 | 2005 | Understanding cardiac arrhythmias. | 
| + | - | nl | Arch Dis Child 90(10):1086-90 (2005) Chakrabarti S |
| 44 | 1985 | The technique of catheter ablation of cardiac arrhythmias. | 
| + | - | nl | Chest 88(5):647-8 (1985) |
| 45 | 1985 | Antiarrhythmic drug therapy (Part 2). Benefits and hazards. | 
| + | - | nl | Chest 88(4):618-24 (1985) |
| 46 | 2008 | The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias. | 
| + | - | nl | Circ Arrhythm Electrophysiol 1(5):396-404 (2008) Yamada T |
| 47 | 2003 | Recent advances in the treatment of arrhythmias. | 
| + | - | nl | Circ J 67(8):651-5 (2003) Grant AO |
| 48 | 2003 | A surprising new arrhythmia mechanism in heart failure. | 
| + | - | nl | Circ Res 93(7):589-91 (2003) Roden DM |
| 49 | 2003 | Antiarrhythmic drug target choices and screening. | 
| + | - | nl | Circ Res 93(6):491-9 (2003) Sanguinetti MC |
| 50 | 1984 | Antiarrhythmic drug action. Blockade of the inward sodium current. | 
| + | - | nl | Circ Res 55(4):427-39 (1984) |
| 51 | 1981 | Cellular mechanisms for cardiac arrhythmias. | 
| + | - | nl | Circ Res 49(1):1-15 (1981) |
| 52 | 1977 | Action potentials, afterpotentials, and arrhythmias. | 
| + | - | nl | Circ Res 41(4):415-23 (1977) |
| 53 | 1973 | Mechanisms of action of antiarrhythmic drugs. | 
| + | - | nl | Circ Res 32(1):1-8 (1973) |
| 54 | 2008 | ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. | 
| + | - | nl | Circulation 117(21):e350-408 (2008) Epstein AE |
| 55 | 2007 | Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. | 
| + | - | nl | Circulation 116(20):2325-45 (2007) Lehnart SE |
| 56 | 2005 | Molecular basis of arrhythmias. | 
| + | - | nl | Circulation 112(16):2517-29 (2005) Shah M |
| 57 | 2003 | ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). | 
| + | - | nl | Circulation 108(15):1871-909 (2003) Blomstrom-Lundqvist C |
| 58 | 2001 | New approaches to antiarrhythmic therapy, Part I: emerging therapeutic applications of the cell biology of cardiac arrhythmias. | 
| + | - | nl | Circulation 104(23):2865-73 (2001) |
| 59 | 1999 | Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. | 
| + | - | nl | Circulation 99(5):674-81 (1999) |
| 60 | 1999 | Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. | 
| + | - | nl | Circulation 99(4):518-28 (1999) |
| 61 | 2001 | New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias. | 
| + | - | nl | Eur Heart J 22(23):2148-63 (2001) |
| 62 | 2001 | Immunological basis of the cardiac conduction and rhythm disorders. | 
| + | - | nl | Eur Heart J 22(10):813-24 (2001) |
| 63 | 1999 | Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology. | 
| + | - | nl | Eur Heart J 20(3):174-95 (1999) |
| 64 | 1998 | The search for novel antiarrhythmic strategies. Sicilian Gambit. | 
| + | - | nl | Eur Heart J 19(8):1178-96 (1998) |
| 65 | 1997 | Dispersion of repolarization. A basic electrophysiological mechanism behind malignant arrhythmias. | 
| + | - | nl | Eur Heart J 18(8):1200-2 (1997) |
| 66 | 1997 | Abnormal dynamics of ventricular repolarization--a new insight into the mechanisms of life-threatening ventricular arrhythmias. | 
| + | - | nl | Eur Heart J 18(6):893-5 (1997) |
| 67 | 1996 | Non-pharmacological treatment of supraventricular arrhythmias. | 
| + | - | nl | Eur Heart J 17 Suppl C(-):26-34 (1996) |
| 68 | 2002 | Patients with ventricular arrhythmias: who should be referred to an electrophysiologist? | 
| + | - | nl | Heart 88(5):544-50 (2002) |
| 69 | 2001 | Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study. | 
| + | - | nl | Heart 86(2):219-20 (2001) |
| 70 | 2001 | Radiofrequency catheter ablation of supraventricular arrhythmias. | 
| + | - | nl | Heart 85(5):594-600 (2001) |
| 71 | 2000 | Antiarrhythmic drugs: from mechanisms to clinical practice. | 
| + | - | nl | Heart 84(3):339-46 (2000) |
| 72 | 2000 | Antiarrhythmics--from cell to clinic: past, present, and future. | 
| + | - | nl | Heart 84(1):14-24 (2000) |
| 73 | 1992 | Modulation of potassium channels by antiarrhythmic and antihypertensive drugs. | 
| + | - | nl | Hypertension 19(3):228-36 (1992) |
| 74 | 1999 | Management of ventricular arrhythmias: detection, drugs, and devices. | 
| + | - | nl | JAMA 281(2):172-9 (1999) |
| 75 | 2006 | Modern management of arrhythmias. | 
| + | - | nl | Postgrad Med J 82(964):117-25 (2006) Hall MC |
| 76 | 1985 | Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents. | 
| + | - | nl | Postgrad Med J 61(718):665-77 (1985) |
| 77 | 1999 | Ventricular arrhythmias in congestive heart failure: clinical significance and management. | 
| + | - | nl | Tex Heart Inst J 26(1):42-59 (1999) |
| 78 | 1984 | Recent trends in the management of life-threatening ventricular arrhythmias. | 
| + | - | nl | West J Med 141(5):649-65 (1984) |
| 79 | 1977 | Medical staff conference. The significance and treatment of long-term ventricular arrhythmias. | 
| + | - | nl | West J Med 126(3):209-14 (1977) |
| 80 | 2004 | Cardiac arrhythmias: the quest for a cure: a historical perspective. | 
| + | - | nl | J Am Coll Cardiol 44(6):1155-63 (2004) Wellens HJ |
| 81 | 2003 | ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. | 
| + | - | nl | J Am Coll Cardiol 42(8):1493-531 (2003) Blomstrom-Lundqvist C |
| 82 | 1988 | Ventricular arrhythmias. | 
| + | - | nl | CMAJ 138(10):903-13 (1988) |
| 83 | 2010 | A sympathetic model of L-type Ca2+ channel-triggered arrhythmias. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 298(1):H3-4 (2010) Best JM |
| 84 | 2007 | Mechanisms of human arrhythmia syndromes: abnormal cardiac macromolecular interactions. | 
| + | - | nl | Physiology (Bethesda) 22(-):342-50 (2007) |
| 85 | 2010 | Drug-induced arrhythmia. | 
| + | - | nl | Circulation 122(14):1426-35 (2010) |
| 86 | 2007 | Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. | 
| + | - | nl | Circulation 116(10):e320-35 (2007) |
| 87 | 2005 | Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve. | 
| + | - | nl | Circulation 112(10):1376-8 (2005) Roden DM |
| 88 | 2008 | Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. | 
| + | - | nl | Circulation 117(14):1890-3 (2008) |
| 89 | 2009 | From the ryanodine receptor to cardiac arrhythmias. | 
| + | - | nl | Circ J 73(9):1561-7 (2009) |
| 90 | 2010 | Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins. | 
| + | - | nl | Circ Res 107(4):457-65 (2010) |
| 91 | 2002 | Calcium and cardiac rhythms: physiological and pathophysiological. | 
| + | - | nl | Circ Res 90(1):14-7 (2002) |
| 92 | 2004 | Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. | 
| + | - | nl | Cardiovasc Res 62(2):323-34 (2004) |
| 93 | 2007 | Do statins have an antiarrhythmic activity? | 
| + | - | nl | Cardiovasc Res 75(1):10-20 (2007) |
| 94 | 2009 | Phosphoinositide signalling and cardiac arrhythmias. | 
| + | - | nl | Cardiovasc Res 82(2):286-95 (2009) |
| 95 | 2008 | The sarcoplasmic reticulum and arrhythmogenic calcium release. | 
| + | - | nl | Cardiovasc Res 77(2):285-92 (2008) |
| 96 | 2007 | Detection and reporting of drug-induced proarrhythmias: room for improvement. | 
| + | - | nl | Europace 9 Suppl 4(-):iv23-36 (2007) |
| 97 | 2009 | From mitochondrial dynamics to arrhythmias. | 
| + | - | nl | Int J Biochem Cell Biol 41(10):1940-8 (2009) |
| 98 | 2011 | Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. | 
| + | - | nl | Dtsch Arztebl Int 108(37):623-33; quiz 634 (2011) |
| 99 | 2005 | Approaching cardiac arrhythmias in the elderly patient. | 
| + | - | nl | MedGenMed 7(4):24 (2005) |
| 100 | 2006 | Arrhythmias in the elderly: modern management. | 
| + | - | nl | Hellenic J Cardiol 47(2):84-92 (2006) |
| 101 | 2010 | Genetic testing for inherited cardiac arrhythmias. | 
| + | - | nl | Hellenic J Cardiol 51(2):92-103 (2010) |
| 102 | 2009 | Cardiovascular translational medicine (IV): The genetic basis of malignant arrhythmias and cardiomyopathies. | 
| + | - | nl | Rev Esp Cardiol 62(4):422-36 (2009) |
| 103 | 2004 | Perioperative cardiac arrhythmias. | 
| + | - | nl | Br J Anaesth 93(1):86-94 (2004) |